Ibio Return On Equity Over Time
| IBIO Stock | USD 2.54 0.02 0.78% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ibio Performance and Ibio Correlation. Ibio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Return On Equity Analysis
Compare Ibio Inc and related stocks such as Jaguar Animal Health, Onconova Therapeutics, and GeoVax Labs Return On Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAGX | (7.8538) | (7.8538) | (7.8538) | (7.8538) | (7.8538) | (3.7034) | 6.0035 | (1.2727) | (5.9716) | (3.6107) | (2.1388) | (5.1891) | 72.2283 | (8.3249) | (7.91) |
| GOVX | 11.8558 | (3.3354) | (1.855) | (0.9041) | (2.3849) | (2.2325) | (13.6111) | 6.7594 | 2.5049 | 1.5084 | (0.3071) | (4.2484) | (0.5269) | (4.5055) | (4.28) |
| OCGN | 0.8592 | 0.8592 | 0.8592 | 0.3403 | (0.4205) | (1.1357) | (1.1947) | 2.3442 | 18.8712 | (1.9264) | (1.0498) | (0.6091) | (0.926) | (1.555) | (1.48) |
| TNXP | (0.4925) | 1.4141 | (0.0099) | (1.6714) | (0.7652) | (1.1935) | (1.5316) | (0.8581) | (1.2405) | (3.3017) | (0.5953) | (0.4219) | (0.5641) | (1.1055) | (1.16) |
| SONN | 1.7691 | 1.7691 | 1.7691 | (0.5304) | 1.7691 | (0.5578) | (0.7079) | (0.6346) | (0.9225) | (10.2853) | (1.1234) | 11.7281 | 83.3379 | (0.9225) | (0.88) |
| PALI | (2.0277) | (7.5421) | (1.4516) | (2.3558) | (1.2771) | (4.2083) | (1.8599) | (1.8398) | (0.814) | (1.6293) | 0.6367 | (3.7028) | (1.0256) | (1.0872) | (1.14) |
| VXRT | (0.1772) | (0.077) | (0.1309) | (0.1266) | (0.2748) | (0.5498) | (1.5722) | 0.3218 | (1.6023) | (1.4395) | (0.2611) | (0.3758) | (0.9743) | (1.4266) | (1.36) |
| ADMA | (6.4819) | (0.7748) | (0.7748) | (0.7197) | (2.7982) | (21.8885) | 4.3783 | (1.0849) | (3.3253) | (2.1779) | (0.9927) | (0.5982) | (0.5605) | (0.2089) | (0.2) |
| BCRX | (0.6161) | (3.8463) | 0.0995 | 0.0712 | 0.0966 | 0.0842 | 0.0974 | 0.1041 | 0.1383 | 0.1428 | 0.1921 | 0.1524 | 0.1699 | 0.4973 | 0.52 |
Ibio Inc and related stocks such as Jaguar Animal Health, Onconova Therapeutics, and GeoVax Labs Return On Equity description
Return on Equity is the amount of Ibio Inc net income returned as a percentage of Ibio equity. Return on equity measures Ibio profitability by revealing how much profit Ibio Inc generates with the money shareholders have invested. A measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity.My Equities
My Current Equities and Potential Positions
| Ibio Inc | IBIO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NYSE MKT Exchange |
USD 2.54
Check out Ibio Performance and Ibio Correlation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Ibio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.